Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation Inhibition of SH T04769G vs Valette in Healthy Women
NCT00471991Phase 2Completed
- Sponsor
- Bayer
- Start
- Apr 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dienogest + ethinyl estradiol in contraception (2 arms), sponsored by Bayer. Primary endpoint: Ovulation inhibition in Cycle 2 at Cycle 2. Started Apr 2007; status: completed.
02
Drugs
dienogest + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00471991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00471991.